$1.15
$-0.07 (-6.09%)
End-of-day quote: 05/16/2024
NasdaqGM:ACRX
AcelRx Pharmaceuticals Annual Report
| Year | Year | 2010 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.65M | $2.82M | $5.42M | $2.29M | $2.15M | $8.00M | $17.36M | $19.26M | $5.22M | $29.50M | $2.39M | $1.07M | |
| GM % | Gross Margin % |
|
0.00% | 23.50% | -0.94% | -25.48% | 0.00% | 0.00% | -276.09% | -94.26% | -25.93% | 0.00% | 10.88% | 0.00% | 0.00% | |
| OM | Operating Margin |
|
0.00% | 0.00% | -21.02% | 0.00% | 0.00% | 0.00% | 0.00% | -184.12% | -99.66% | 0.00% | -22.60% | 0.00% | 0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $-0.39 | $-5.80 | $-9.40 | $-13.40 | $-16.20 | $-22.00 | $-21.89 | $-11.00 | $-20.99 | $-17.80 | $-30.20 | $-23.20 | $-31.20 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | -0.00% | -0.00% | -0.00% | -0.00% | 0 | 0 | 0 | 0 | 0 | 0 | |
| Sha. | Shares |
|
0.03m | 16.95m | -473.45m | 98.81m | 79.57m | 78.76m | 50.9m | 45.33m | 45.27m | 43.71m | 43.05m | 37.06m | 19.57m | |
| OCF | Operating Cash Flow |
|
$-12.23M | $-17.49M | $-29983000.00M | $-38.51M | $-51.18M | $-29.08M | $-29.77M | $-29.40M | $-19.95M | $-34.46M | $-0.49M | $-24.58M | $-15.29M | |
| FCF | Free Cash Flow |
|
$0.00M | $-17.59M | $-31810000.00M | $-40.36M | $-54.65M | $-29.89M | $-32.17M | $-33.12M | $-21.41M | $-39.96M | $-3.77M | $-25.41M | $-17.31M | |
| FCFS | Free Cash Flow Per Share |
|
$-372.46 | $-1.23 | $-0.27 | $-0.47 | $-0.69 | $-0.51 | $-0.69 | $-0.73 | $-0.48 | $-0.92 | $-0.09 | $-1.15 | $-1.00 |
